Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of recombinant human heat shock protein
70-polyvalent peptide complex (HerpV) vaccine administration on recurring episodes of genital
herpes by evaluating viral shedding before and after treatment.